|
Productname |
 CIC-C3d MicroVue™ Quidel® |
|
|
Raji-Cell-Replacement Quantification of circulating immune complexes with C3 Activation Fragments
|
|
Cat-No. |
A002 |
|
Range |
5 - 48 µg Eq/ml |
|
Sensitivity |
4 µg Eq/ml |
|
Incubation time |
2 hours |
|
Sample volume |
10 µl (dilute 1:50) |
|
Sample type |
Serum and plasma
|
|
Sample preparation |
All specimens should be collected aseptically. Do not heat-inactivate the specimens. Samples may be stored on ice for up to 6 hours.
For longer periods store below -70 ºC.
|
|
Reference values |
Normal ≤ 15 µg Eq/ml
Abnormal ≥ 20 µg Eq/ml
|
|
Species |
Human
|
|
Specificity |
Immobilized monoclonal anti human C3 fragments capture C3d containing immune complexes.
|
|
Tests |
96 Tests |
|
Method |
ELISA |
|
Product informations |
- Literature: Complement Diagnostics (pdf-File 1,850 kb)
- Kit Instructions (pdf-File 218 kb)
- Cross-reaction all species (pdf-File 71 kb)
- Datasheet (pdf-File 438 kb) |
|
Intended use |
The CIC-RCR Assay is designed for the detection of circulating immune complexes (CIC) in human serum
or plasma. CIC have been measured in a variety of conditions: infections, autoimmune disorders, trauma and neoplastic proliferative diseases. In addition the measurement of CIC can be important for the
evaluation of certain forms of rheumatoid arthritis and for monitoring the effectiveness of therapy.
|
|
Keywords product |
CIC-RCR, ELISA, Quantification of circulating immune complexes, Rheumatoid Arthritis, CIC-Raji-Cell-Replacement, Complement pathway, Complement cascade
|